| HOME >> MEDICINE >> TECHNOLOGY |
INFORMATION SOURCES
Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also mined, as well as publications of relevant trade associations such as the Generic Pharmaceutical Association (GPhA) and the European Generic Medicines Association (EGA).
CHAPTER ONE: INTRODUCTION 1
STUDY GOALS AND OBJECTIVES . 1
REASONS FOR DOING THE STUDY .. 1
SCOPE OF REPORT .. 2
MARKET ANALYSES AND FORECASTS ... 2
METHODOLOGY ... 2
INTENDED AUDIENCE 3
INFORMATION SOURCES ... 3
ANALYST CREDENTIALS 3
RELATED REPORTS . 3
BCC ONLINE SERVICES .. 4
DISCLAIMER . 4
CHAPTER TWO: SUMMARY .. 5
SUMMARY .. 5
MARKET SIZE AND EVOLUTION ... 6
SUMMARY TABLE MAJOR GENERICS MARKETS, THROUGH 2016 ($
BILLIONS) ... 7
SUMMARY FIGURE MAJOR GENERICS MARKETS, THROUGH 2016
($ BILLIONS) ... 7
CHAPTER THREE: OVERVIEW 8
OVERVIEW . 8
OVERVIEW (CONTINUED) ... 9
TABLE 1 GLOBAL PHARMACEUTICAL AND GENERICS MARKETS,
THROUGH 2016 ($ BILLIONS) ... 10
RECENT HISTORY OF THE GENERICS SECTOR .. 11
ROCHE-BOLAR . 11
Roche-Bolar (Continued) . 12
GENERICS LOBBY ... 13
ICH .. 14
CHAPTER FOUR: THE NEW GENERICS ERA .. 15
THE PATENT CLIFF ... 16
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |